About J.D. Kleinke
J.D. Kleinke is a health care entrepreneur and author. He has been instrumental in the creation of four health care information organizations, served on the Boards of several public and privately held health care companies, and advised both sides of the political aisle on pragmatic approaches to health policy and legislation.
He is currently an investor in and active mentor to health care information technology providers Wildflower Health and Context Matters, and a member of the Board of Directors of Primary Care Progress, a physician education non-profit.
In 2012, Kleinke served as a Fellow of the American Enterprise Institute. Prior to joining AEI, Kleinke was CEO of Mount Tabor, a health care information technology development company created in 2007 to plan, design, build, test and launch systems for the transformation and movement of electronic medical information.
In 2004, Kleinke founded Omnimedix Institute, a 501-c-3 charitable organization dedicated to the development and promotion of technologies that give patients and their families safe and secure access to, and control over, their own medical data. Prior to creating Omnimedix, Kleinke helped establish Health Grades Inc., a publicly traded health care information company, which he served as Executive Vice Chairman until 2006.
In the 1990s, Kleinke helped grow HCIA (now Truven Health Analytics) from a niche hospital data analysis firm into a pioneering, publicly-traded health information products and services company. Before joining HCIA, he was Director of Corporate Programs at Sheppard Pratt Health System, the largest private psychiatric hospital in the U.S. While at Sheppard Pratt, Kleinke developed and managed the nation’s first provider-based, managed mental health care system.
He has authored three books on the U.S. health care system, Bleeding Edge: The Business of Health Care in the New Century (1998), Oxymorons: The Myth of a US Health Care System (2001), and Catching Babies (2011). He has also published numerous articles and essays in The Wall Street Journal, New York Times, Barron’s, Health Affairs, JAMA, the British Medical Journal, Modern Healthcare, Managed Healthcare, and Forbes.com.
Provider of drug reimbursement and clinical information products, and related drug data management services, to pharmaceutical companies and financial institutions.
Provider of mobile health systems to patients and families, on behalf of commercial and Medicaid health plans, state Medicaid programs, and employers.
Non-profit organization that provides management education and leadership training services to US physicians.
Kleinke worked with the AEI health care team to produce and publish original research on President Obama’s health care reform law. He studied and wrote about the potential impacts of the law on health care market dynamics, health venture formation, and medical innovation. He also studied and led AEI events on the influence of information technology, medical technology, and physician culture on health care organizations, patient care, and the public health.
Kleinke co-founded and led Mount Tabor, a health care information technology development company founded in 2007 to plan, design, build, test and launch systems for the transformation and movement of electronic medical information. Mount Tabor provided business strategy and technology integration services for health care companies, technology providers, and government entities creating health information products, systems and services. Mount Tabor helped build, launch and test the Google Health personal health information platform and supported implementation of the Microsoft HealthVault personal health information platform.
Kleinke founded and led the Omnimedix Institute, a 501-c-3 charitable organization that created, built and promoted information technologies for giving patients and their families safe and secure access to and control over their own medical data. With funding from private foundations, public corporations, and the federal government, Omnimedix developed and deployed open and ubiquitous health information technologies designed to increase patient access to the health care system; to data on their own medical care; and to information about the best care available for their medical condition.
Executive Vice Chairman of the Board of Directors, 2004 – 2006
Member of Board of Directors, 2002 – 2008
Kleinke served on the Board of Health Grades Inc., a publicly traded health care information company, from 2002 until 2008. Until the rapid expansion of Omnimedix in 2006, he served as the Board’s Executive Vice Chairman. The mission of Health Grades is to improve the quality of health care nationwide, through the creation and marketing of objective, third party information about the quality of care delivered by hospital, physicians, and nursing homes across the U.S.. During Kleinke’s tenure, the company’s revenue increased more than 10-fold, and its share price increased from $0.06 to $7.70.
Kleinke founded and led HSN, a health care business and information technology strategy company. HSN created and operated Pharmapath.com, a Web-based managed care reimbursement business that assisted physicians and patients in securing reimbursement for pharmaceutical and biotechnology products; provided health information technology strategy services for several major software companies, health care organizations, and not-for-profit foundations; and developed, tested and deployed customized Web-based software for managed care organizations, pharmaceutical companies, and not-for-profit health care organizations.
Vice President, Corporate Development, 1996-1998
Vice President, Managed Care Unit, 1995-1996
Senior Director, Pharmaceutical Market Research Unit, 1993-1995
Director, Marketing and Product Development, 1992-1993
Kleinke was a principal architect in the creation and rapid growth of HCIA from a niche health care data analysis firm with $3 million in 1992 revenues to a $79 million per year, publicly traded provider of information products to health care systems, managed care organizations, and pharmaceutical companies across the U.S. and Europe. In various roles, Kleinke was responsible for generating and managing business unit revenues in excess of $15 million. He also directed HCIA’s analyses of the impact of changing clinical practices on the US health care economy; helped establish high-visibility media relations department; and published articles promoting the company’s data and analysis in the Wall Street Journal, JAMA, Barron’s, Modern Healthcare, Business & Health, Managed Healthcare, and Health Affairs.
Sheppard Pratt Preferred Resources, Inc., Baltimore, MD
Sheppard Pratt Hospital/The Sheppard & Enoch Pratt Health System
Kleinke developed and managed the nation’s first provider-based behavioral health care delivery system, Sheppard Pratt Preferred Resources, the for-profit group mental health subsidiary of Sheppard Pratt Hospital, the largest private psychiatric facility in the U.S. Within its first year of operation, the system provided and managed fully capitated behavioral health care benefits for more than 150,000 covered lives.
- Member, Editorial Board, Managed Healthcare Executive, 1998 – 2015
- Member, Board of Advisors, Medtronic, 2003 – 2007
- Guest Lecturer, Harvard School of Public Health, 1998 – 2007
- Member, Scientific Advisory Panel, Merck & Company, 2000 – 2005
- Member, Editorial Board, Health Affairs, 1995 – 2003
- Advisor, Health Technology Ventures, Goldman Sachs, 2000 – 2002
- Member, Board of Directors, RIMS Inc., 1998 – 2001 (acquired by Trizetto)
- Affiliate, Institute for the Future, 2001– 2002.
- Guest Lecturer, Johns Hopkins University, 1996 – 1998
“The Conservative Case for Obamacare,” The New York Times, Sunday Review, September 30, 2012
“There’s a Medical App for That – Or Not” The Wall Street Journal, (with Scott Gottlieb), May 30, 2012.
“The Myth of Runaway Health Spending,” The Wall Street Journal, February 17, 2012.
“Follow The Money,” Health Affairs, March/April 2009; 28(2): 586-587.
“Silicon Valley To The Rescue, Version 2.0” Health Affairs, September/October 2007; 26; 5.
“Health Care’s Next Holy War: Evidence Based-Medicine,” Journal of Managed Care Pharmacy 11, No. 4 Supp. (2005): S3–S6.
“Dot-Gov: Market Failure And The Creation Of A National Health Information Technology System,” Health Affairs, September/October 2005; 24; 5.
“Turning Point For The Health Care Blame Cycle?” Health Affairs, January/February 2005; 24; 1.
“Re-Naming And Re-Gaming: Medicare’s Doomed Attempt To Reform Reimbursement For Injectable Drugs,” Health Affairs, December 8, 2004, Web Exclusive.
“eGads! A Health Futurist Lost In Cyberspace,” Health Affairs, March/April 2004; 23; 2.
“Final Underwriting Death Spiral,” Managed Care Magazine, January 2004.
“Access versus Excess: Value-Based Cost-Sharing for Prescription Drugs,” Health Affairs, January/February 2004; 23; 1.
“Requiem for Research,” Barron’s, September 8, 2003.
“How to Revive Health Care,” Barron’s, June 17, 2002.
“Medicine’s Industrial Revolution,” Aetna Annual Report 2001, April 2002.
“The Price of Progress: Prescription Drugs in the Health Care Market,” Health Affairs, September/October 2001; 20; 5; 43.
“Vaporware.com: The Failed Promise of the Health Care Internet,” Health Affairs, November/December, 2000; 19; 6; 57.
“Just What the HMO Ordered: The Paradox of Increasing Drug Costs,” Health Affairs, March/April 2000; 19; 2; 78.
“HMOs: The Law and Economics,” Barron’s, December 13, 1999.
“Release 0.0: Clinical Information Technology in the Real World,” Health Affairs, November/December 1998.
“Taking Physicians Captive,” Modern Healthcare, 9 November 1998.
“Bigger Wasn’t Better for the Dinosaurs, Either,” Managed Healthcare, October 1998.
“Is the FDA approving drugs too fast?” (with Scott Gottlieb), British Medical Journal (BMJ), Volume 317, 3 October 1998, 899-900.
“Why Merger Mania is Unhealthy for HMOs,” The Wall Street Journal, 17 August 1998.
“Deconstructing the Columbia/HCA Investigation,” Health Affairs, March/April 1998.
“100 Top Hospitals,” Managed Healthcare, February 1998.
“Power to the Patient,” Modern Healthcare, 23 February 1998.
“Managed Care Meltdown,” Barron’s, 22 December 1997.
“The Industrialization of Health Care,” Journal of the American Medical Association (JAMA), Volume 278, Number 17, November 5, 1997, 1456-57.
“Medicine’s Industrial Revolution,” The Wall Street Journal, 21 August 1995.
“How to Save on Medicare and Survive,” The Wall Street Journal, 17 January 1995.
“Triumph of the Market,” Barron’s, 24 October 1994.
“Employers Can Do It Without Mandates,” The Wall Street Journal, 11 May 1994.
With D Foster and J Young-Hassler, “Increased cholecystectomy rate after introduction of laparoscopic cholecystectomy,” Journal of the American Medical Association (JAMA), Volume 271, 1994, 500.
“Expensive Drugs Lower Health Care Costs,” The Wall Street Journal, 16 February 1994.
“The Health Care Inflation Fantasy,” The Wall Street Journal, 18 October 1993.
“Managed EAPs,” (with Susan Hahn) in the collection of essays, Driving Down Health Costs, Strategies and Solutions, New York: Panel Publishers, 1992.
“Managed Mental Health for the 1990s: Integrating Managed Care and Employee Assistance,” (with Susan Hahn), Compensation & Benefits Management, Volume 7, Number 4, Fall 1991.